Reaction

Deafness Congenital reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 201 reports · 4 co-occurring drugs

As of the last recalculation, Deafness Congenital appears in 201 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 242.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Valganciclovir Hydrochloride Powder,25242.3242.8
Valganciclovir26163.9164.1
Valganciclovir Hydrochloride26163.9164.1
Cefuroxime12115.5115.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.